T1 bladder carcinoma with variant histology: pathological features and clinical significance
Antonio López-Beltrán(University of Córdoba), Liang Cheng(Brown University), Rodolfo Montironi(Marche Polytechnic University), Metka Volavšek(University of Ljubljana), Rafael J. Luque(Complejo Hospitalario de Jaén), Alessia Cimadamore(University of Udine), Ana Blanca(Instituto Maimónides de Investigación Biomédica de Córdoba)
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
February 4, 2022
Cited by 31
Related Papers
Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
|Modern Pathology|2017|404
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
|Cancers|2021|289